With exquisitely bad timing, the National Institutes of Heath (NIH) floated a new policy governing licensing inventions made by its scientists subtitled “Promoting Equity in Access Planning.”. With stakeholders still stunned by the Administration’s attempt to misuse the Bayh-Dole Act to impose Washington price controls on products based on federally funded inventions, the new plan could hardly have been floated at a worse time. The document asks for public comments by July 22, 2024.
Recent Posts
- CAFC Affirms TTAB Ruling that FIREBALL is Not Generic but Competitor’s Mark Won’t Confuse
- John Squires Becomes Official Nominee to Head USPTO
- Other Barks & Bites for Friday, March 7: Lashify Wins ITC Appeal on Economic Prong Analysis; CAFC Says Apple Did Not Violate Discovery Obligations at PTAB; and ParkerVision Files Reply Brief on Rule 36 Appeal at SCOTUS
- Rio Tinto is Seeking an IP Counsel Innovation & Technology
- Moderna COVID Vaccine Technology Struck Down by PTAB